Filter Results :

Your search for Cancer returned 1072 reports

Sort by


Ovarian Cancer: KOL Insight

27 Feb 2015  |  Published by:  FirstWord
Ovarian Cancer: KOL Insight, A new era of targeted therapy provides leading clinician insights on new ovarian cancer (OC) drugs at a time of significant change in the therapy landscape. Why This Report is Essential A number of targeted therapies including VEGF, angiopoietin, PARP and MEK ...

$ 7,495.00

Read More

Cancer Nanomedicine Market & Pipeline Insight 2015

25 Feb 2015  |  Published by:  KuicK Research
During the last decade, there has been significant impact of the emergence of nanotechnology on clinical therapeutics. The pharmaceutical industry has witnessed advances in biocompatible nanoscale drug carriers in the form of liposomes and polymeric nanparticles which have the potential to del...

$ 2,000.00

Read More

Global Skin Cancer Vaccine Market & Pipeline Insight 2015

24 Feb 2015  |  Published by:  KuicK Research
Skin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing better therapeutic options for patients. Skin cancer therapeutics available in market used fo...

$ 1,500.00

Read More

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

24 Feb 2015  |  Published by:  KuicK Research
Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targ...

$ 1,200.00

Read More

Therapeutics for Silent Cancers

19 Feb 2015  |  Published by:  BCC Research
The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019. This report provides:-An overview of the global markets and tec...

$ 6,650.00

Read More

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline.This report provides compre...

$ 2,000.00

Read More

Head And Neck Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at var...

$ 2,000.00

Read More

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015’, provides an overview of the Human papillomavirus (HPV) Associated Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Human papilloma...

$ 2,000.00

Read More

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Canc...

$ 2,000.00

Read More

Cancer Cachexia - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H1 2015’, provides an overview of the Cancer Cachexia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cancer Cachexia, complete with comparative analysis at various stages, th...

$ 2,000.00

Read More

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

26 Jan 2015  |  Published by:  MarketsandMarkets
Report Description The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment ...

$ 4,650.00

Read More

Small Molecule Cancer Drug Clinical Pipeline Insight

22 Jan 2015  |  Published by:  PNS Pharma
Oncologists are continuously looking for better therapeutic options to effectively cure and prevent different types of malignancies. Conventionally, surgery and radiation were widely used for cancer treatment but they have modest benefits. Presently, global market consists of several options f...

$ 2,400.00

Read More

Dermatology Devices Market by Diagnostic Devices (Dermatoscope, Microscope, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) - Global Forecast to 2019

22 Jan 2015  |  Published by:  MarketsandMarkets
Report Description In this report, the dermatology devices market is segmented on the basis of applications, products, and geographies. The application segments included in this report are diagnostic applications and treatment applications. The diagnostic applications are further segmented ...

$ 4,650.00

Read More

Breast Cancer - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug t...

$ 2,500.00

Read More

Peritoneal Cancer - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessme...

$ 2,000.00

Read More
Total 1072 records.